CORMORANT ASSET MANAGEMENT, LP purchased 17.3% of their position (350K shares) of CORBUS PHARMACEUTICALS HOLDINGS, INC. on the open market
Open‑market purchase worth $7.00M — a significant purchase. The strongest form of insider conviction signal.
P · 6 purchases
Filed: 9/24/2024ACC: 0000929638-24-003217
→
10% Owner
Since Jan 2024
+350K
Net shares
Net buyer
$7.00M
Total acquired
6
Open market trades
6B · 0S
6
Total transactions
350K acquired
Non-Derivative Transactions6
Common Stock
Indirect
Shares
+45.09K
Price / share
$17.48
Trade value
$787.86K
% of position
2.2%
9/20/2024
2.02M→2.07M
Common Stock
Indirect
Shares
+25.94K
Price / share
$18.36
Trade value
$476.31K
% of position
1.3%
9/20/2024
2.07M→2.10M
Common Stock
Indirect
Shares
+66.09K
Price / share
$19.61
Trade value
$1.30M
% of position
3.2%
9/20/2024
2.10M→2.16M
Common Stock
Indirect
Shares
+139.55K
Price / share
$20.42
Trade value
$2.85M
% of position
6.5%
9/20/2024
2.16M→2.30M
Common Stock
Indirect
Shares
+47.56K
Price / share
$21.47
Trade value
$1.02M
% of position
2.1%
9/20/2024
2.30M→2.35M
Common Stock
Indirect
Shares
+25.77K
Price / share
$22.23
Trade value
$572.79K
% of position
1.1%
9/20/2024
2.35M→2.38M
Total
Net shares
+350K
Net value
$7M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/20/2024 | P · Purchase | +45.09K | $17.48 | $787.86K | 2.2% | 2.02M | 2.07M |
| Common Stock Indirect | 9/20/2024 | P · Purchase | +25.94K | $18.36 | $476.31K | 1.3% | 2.07M | 2.10M |
| Common Stock Indirect | 9/20/2024 | P · Purchase | +66.09K | $19.61 | $1.30M | 3.2% | 2.10M | 2.16M |
| Common Stock Indirect | 9/20/2024 | P · Purchase | +139.55K | $20.42 | $2.85M | 6.5% | 2.16M | 2.30M |
| Common Stock Indirect | 9/20/2024 | P · Purchase | +47.56K | $21.47 | $1.02M | 2.1% | 2.30M | 2.35M |
| Common Stock Indirect | 9/20/2024 | P · Purchase | +25.77K | $22.23 | $572.79K | 1.1% | 2.35M | 2.38M |
| Total | +350K | $7M | ||||||
Derivative Transactions0
No derivative transactions reported